130 related articles for article (PubMed ID: 9440632)
21. Lansoprazole: an update of its place in the management of acid-related disorders.
Matheson AJ; Jarvis B
Drugs; 2001; 61(12):1801-33. PubMed ID: 11693467
[TBL] [Abstract][Full Text] [Related]
22. Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence.
Bianchi Porro G; Lazzaroni M; Bargiggia S; Maconi G; Trespi E; Perego M; Alvisi C; Villani L; Luinetti O; Fiocca R; Franceschi M; Cesana B; Solcia E
Am J Gastroenterol; 1996 Apr; 91(4):695-700. PubMed ID: 8677931
[TBL] [Abstract][Full Text] [Related]
23. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
[TBL] [Abstract][Full Text] [Related]
24. Comparison of once daily doses of lansoprazole (15, 30, and 60 mg) and placebo in patients with gastric ulcer.
Avner DL; Movva R; Nelson KJ; McFarland M; Berry W; Erfling W
Am J Gastroenterol; 1995 Aug; 90(8):1289-94. PubMed ID: 7639232
[TBL] [Abstract][Full Text] [Related]
25. Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine.
Hawkey CJ; Long RG; Bardhan KD; Wormsley KG; Cochran KM; Christian J; Moules IK
Gut; 1993 Oct; 34(10):1458-62. PubMed ID: 8244121
[TBL] [Abstract][Full Text] [Related]
26. Lansoprazole for maintenance therapy of peptic ulcer disease: weekend full-dose or everyday half-dose administration?
Hoshino E; Umeda N; Sano J; Miki K; Yahagi N; Oka M; Kimura M; Miyashita H
J Clin Gastroenterol; 1995; 20 Suppl 2():S72-4. PubMed ID: 7594346
[TBL] [Abstract][Full Text] [Related]
27. The effects of short-term lansoprazole therapy on Helicobacter pylori infection and antral gastritis in duodenal ulcer patients.
Jhala NC; McFarland MM; Brightman SA; Morale B; Rubin W; Atkinson BF
Am J Gastroenterol; 1995 Oct; 90(10):1824-8. PubMed ID: 7572902
[TBL] [Abstract][Full Text] [Related]
28. Effects of long-term treatment with lansoprazole and omeprazole on serum gastrin and the fundic mucosa.
Arroyo Villarino MT; Lanas Arbeloa A; Esteva Díaz F; Ortego Fernández de Retana J; Sainz Samitier R
Rev Esp Enferm Dig; 1997 May; 89(5):347-56. PubMed ID: 9190140
[TBL] [Abstract][Full Text] [Related]
29. Effects of killing Helicobacter pylori quadruple therapy on peptic ulcer: a randomized double-blind clinical trial.
Feng LY; Yao XX; Jiang SL
World J Gastroenterol; 2005 Feb; 11(7):1083-6. PubMed ID: 15742421
[TBL] [Abstract][Full Text] [Related]
30. Duodenal ulcer healing after 7-day treatment: a pilot study with lansoprazole, amoxicillin and clarithromycin.
Schütze K; Hentschel E
Z Gastroenterol; 1995 Nov; 33(11):651-3. PubMed ID: 8600661
[TBL] [Abstract][Full Text] [Related]
31. [Effectiveness and safety of lansoprazole in the treatment of peptic ulcer].
Ramón Nogueira J; Esquivel Ayanegui F; Esquivel Rodríguez F; Sáenz V; Santoyo R
Rev Gastroenterol Mex; 1996; 61(4):314-9. PubMed ID: 9072782
[TBL] [Abstract][Full Text] [Related]
32. Rank order of success favors longer duration of imidazole-based therapy for Helicobacter pylori in duodenal ulcer disease: a randomized pilot study.
Chaudhary A; Ahuja V; Bal CS; Das B; Pandey RM; Sharma MP
Helicobacter; 2004 Apr; 9(2):124-9. PubMed ID: 15068413
[TBL] [Abstract][Full Text] [Related]
33. Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial.
Sugano K; Kontani T; Katsuo S; Takei Y; Sakaki N; Ashida K; Mizokami Y; Asaka M; Matsui S; Kanto T; Soen S; Takeuchi T; Hiraishi H; Hiramatsu N
J Gastroenterol; 2012 May; 47(5):540-52. PubMed ID: 22388884
[TBL] [Abstract][Full Text] [Related]
34. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
35. Rabeprazole: an update of its use in acid-related disorders.
Carswell CI; Goa KL
Drugs; 2001; 61(15):2327-56. PubMed ID: 11772142
[TBL] [Abstract][Full Text] [Related]
36. Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials.
Laine L; Suchower L; Frantz J; Connors A; Neil G
Am J Gastroenterol; 1998 Nov; 93(11):2106-12. PubMed ID: 9820381
[TBL] [Abstract][Full Text] [Related]
37. One week treatment with omeprazole, clarithromycin and tinidazole or lansoprazole, amoxicillin and metronidazole for cure of Helicobacter pylori infection in duodenal ulcer patients.
Sito E; Konturek PC; Bielański W; Kwiecień N; Konturek SJ; Baniukiewicz A; Jedynak M; Gabryelewicz A; Hahn EG
J Physiol Pharmacol; 1996 Mar; 47(1):221-8. PubMed ID: 8777303
[TBL] [Abstract][Full Text] [Related]
38. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use.
Lai KC; Lam SK; Chu KM; Wong BC; Hui WM; Hu WH; Lau GK; Wong WM; Yuen MF; Chan AO; Lai CL; Wong J
N Engl J Med; 2002 Jun; 346(26):2033-8. PubMed ID: 12087138
[TBL] [Abstract][Full Text] [Related]
39. Lansoprazole and Helicobacter pylori infection.
Pallone F; Luzza F; Delle Fave G; Annibale B; Marcheggiano A; Biancone L; Torsoli A; Capurso L
Clin Ther; 1993; 15 Suppl B():49-57. PubMed ID: 8205595
[TBL] [Abstract][Full Text] [Related]
40. Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy: results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial.
Sugano K; Matsumoto Y; Itabashi T; Abe S; Sakaki N; Ashida K; Mizokami Y; Chiba T; Matsui S; Kanto T; Shimada K; Uchiyama S; Uemura N; Hiramatsu N
J Gastroenterol; 2011 Jun; 46(6):724-35. PubMed ID: 21499703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
